Cutler Group LP Sage Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 200 shares of SAGE stock, worth $2,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Holding current value

$2,222

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$18.62 - $26.95 $3,724 - $5,390	200 New	200 $3,000
Q2 2023 Jul 18, 2023	BUY	$40.65 - $59.54 $7,317 - $10,717	180 Added 2.28%	8,080 $379,000
Q1 2023 May 01, 2023	SELL	$37.27 - $46.57 $11,181 - $13,971	-300 Reduced 3.66%	7,900 $331,000
Q3 2022 Oct 25, 2022	SELL	$32.28 - $43.27 $5,487 - $7,355	-170 Reduced 2.03%	8,200 $321,000
Q2 2022 Aug 04, 2022	SELL	$27.52 - $37.99 $56,828 - $78,449	-2,065 Reduced 19.79%	8,370 $270,000

Q1 2022 Apr 14, 2022	BUY	$30.71 - $45.71 $87,062 - $129,587	2,835 Added 37.3%	10,435 $345,000
Q4 2021 Jan 18, 2022	BUY	$37.06 - $47.11 $26,683 - $33,919	720 Added 10.47%	7,600 $323,000
Q3 2021 Oct 26, 2021	BUY	$40.26 - $57.37 $202,910 - $289,144	5,040 Added 273.91%	6,880 $304,000
Q2 2021 Jul 19, 2021	SELL	$54.88 - $79.29 $114,479 - $165,398	-2,086 Reduced 53.13%	1,840 $104,000
Q1 2021 Apr 26, 2021	BUY	$70.65 - $96.76 $212,091 - $290,473	3,002 Added 324.89%	3,926 $293,000
Q4 2020 Jan 21, 2021	SELL	$58.41 - $89.06 $10,280 - $15,674	-176 Reduced 16.0%	924 $79,000
Q2 2020 Jul 22, 2020	SELL	$25.95 - $43.15 $66,717 - $110,938	-2,571 Reduced 70.04%	1,100 $45,000
Q4 2019 Feb 06, 2020	BUY	$60.18 - $154.77 $130,650 - $336,005	2,171 Added 144.73%	3,671 $265,000
Q2 2018 Aug 10, 2018	BUY	$140.36 - $175.76 $57,126 - $71,534	407 Added 37.24%	1,500 $234,000
Q1 2018 May 11, 2018	BUY	$152.15 - $192.33 $456 - $576	3 Added 0.28%	1,093 $176,000
Q4 2017 Jan 17, 2018	SELL	$60.72 - $167.34 $86,283 - $237,790	-1,421 Reduced 56.59%	1,090 $179,000
Q3 2017 Oct 17, 2017	BUY	$61.4 - $88.52 $154,175 - $222,273	2,511	2,511 $156,000

Others Institutions Holding SAGE

# of Institutions

223

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$63.9 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$60.9 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$54.4 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$52.8 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$49.9 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $660M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account